- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Variant of recombinant human fibroblast growth factor 19
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Variant of recombinant human fibroblast growth factor 19
| EU orphan designation number: | EU/3/15/1584
|
| Active ingredient: | Variant of recombinant human fibroblast growth factor 19 |
| Indication: | Treatment of primary sclerosing cholangitis |
| Sponsor: | Diamond BioPharm Limited
No 4 East Wing Gemini House, Flex Meadow, Harlow, Essex CM19 5TJ, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 16/12/2015 | Orphan designation | EMA/OD/139/15 | (2015)9505 of 14/12/2015 |
CONTACT
EU links
Directorate General Health & Consumers